Host FSTL1 Defines the Impact of Stem Cell Therapy on Liver Fibrosis by Potentiating the Early Recruitment of Inflammatory Macrophages

Researchers investigated the role of follistatin-like 1 (FSTL1), a profibrotic and proinflammatory matricellular protein, in inflammation-related heterogeneity in stem cell therapy.